P&G Plans Health Care Expansion As Prilosec OTC Sales Continue Falling
This article was originally published in The Tan Sheet
Executive Summary
Double-digit percent volume growth in developing markets helped drive Procter & Gamble's health care sales up 5 percent, but the firm says competition for Prilosec OTC continues to cut into its revenues